Fruntealata R, Marius M, Boboc I, Mitran S, Ciurea M, Stoica G
Curr Health Sci J. 2024; 49(3):297-311.
PMID: 38314217
PMC: 10832881.
DOI: 10.12865/CHSJ.49.03.01.
Zhang X, Chen Y, Li S, Wang J, He Z, Yan J
Microbiol Spectr. 2023; 11(3):e0475322.
PMID: 37078873
PMC: 10269733.
DOI: 10.1128/spectrum.04753-22.
Bachmann R, Van Hul M, Baldin P, Leonard D, Delzenne N, Belzer C
Cells. 2022; 11(17).
PMID: 36078075
PMC: 9454966.
DOI: 10.3390/cells11172666.
Bellini R, Bonacina F, Norata G
Front Cardiovasc Med. 2022; 9:934314.
PMID: 35966516
PMC: 9365967.
DOI: 10.3389/fcvm.2022.934314.
Torres A, Collin-Faure V, Diemer H, Moriscot C, Fenel D, Gallet B
Nanomaterials (Basel). 2022; 12(9).
PMID: 35564134
PMC: 9105884.
DOI: 10.3390/nano12091424.
Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies.
Hussain K, Cragg M, Beers S
Cancers (Basel). 2021; 13(19).
PMID: 34638388
PMC: 8507767.
DOI: 10.3390/cancers13194904.
Inflammation and tumor progression: signaling pathways and targeted intervention.
Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y
Signal Transduct Target Ther. 2021; 6(1):263.
PMID: 34248142
PMC: 8273155.
DOI: 10.1038/s41392-021-00658-5.
Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.
Chen A, Gartrell R, Zhao J, Upadhyayula P, Zhao W, Yuan J
Genome Med. 2021; 13(1):88.
PMID: 34011400
PMC: 8136167.
DOI: 10.1186/s13073-021-00906-x.
Overcoming Immune Evasion in Melanoma.
Eddy K, Chen S
Int J Mol Sci. 2020; 21(23).
PMID: 33256089
PMC: 7730443.
DOI: 10.3390/ijms21238984.
Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model.
Zhang C, Chery S, Lazerson A, Altman N, Jackson R, Holt G
Sci Rep. 2020; 10(1):7277.
PMID: 32350353
PMC: 7190699.
DOI: 10.1038/s41598-020-64305-9.
Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X, Liu R, Su X, Pan Y, Han X, Shao C
Mol Cancer. 2019; 18(1):177.
PMID: 31805946
PMC: 6894344.
DOI: 10.1186/s12943-019-1102-3.
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment.
Nakamura K, Smyth M
Cell Mol Immunol. 2019; 17(1):1-12.
PMID: 31611651
PMC: 6952382.
DOI: 10.1038/s41423-019-0306-1.
New Aspects Towards a Molecular Understanding of the Allicin Immunostimulatory Mechanism via Colec12, MARCO, and SCARB1 Receptors.
Toma V, Tigu A, Farcas A, Sevastre B, Taulescu M, Gherman A
Int J Mol Sci. 2019; 20(15).
PMID: 31344978
PMC: 6696194.
DOI: 10.3390/ijms20153627.
The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.
Lundgren S, Karnevi E, Elebro J, Nodin B, Karlsson M, Eberhard J
J Transl Med. 2017; 15(1):152.
PMID: 28673320
PMC: 5496326.
DOI: 10.1186/s12967-017-1256-y.